InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,436.44
(
-0.50%
)
US TECH 100
18,569.20
(
1.46%
)
Dow Jones
40,743.33
(
0.50%
)
Brent Oil
80.12
(
1.97%
)
Bitcoin
65,964.17
(
-0.31%
)
Post# of 651890
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

work-n-hard

Send PM Follow Ignore
Followers 263
Posts 33175
Boards Moderated 2
Alias Born 01/24/2013

work-n-hard

Member Level

Re: None

Monday, 12/11/2023 10:42:40 AM

Monday, December 11, 2023 10:42:40 AM

Post# of 651890
BBLG: Keeping an eye out for: “We are encouraged by the ongoing progress in preparing to advance NB1 into human testing and look forward to the start of our pilot study before the end of the year,” said Jeffrey Frelick, president and chief executive officer of Bone Biologics.

https://www.nasdaq.com/press-release/bone-biologics-provides-scientific-update-on-nb1-bone-graft-device-2023-09-26

A sure sign that the debate has been won:
When the response is an attack against the other person.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up